Clinical trial
Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer
NCT00259285 · Eli Lilly and Company, Industry · Terminated
Key facts
| NCT number | NCT00259285 |
|---|---|
| Title | Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer |
| Official title | Alimta (Pemetrexed) and Cisplatin Treatment as Neoadjuvant Therapy in Non Small Cell Lung Cancer |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small-Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | pemetrexed, cisplatin |
| Enrollment | 10 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Nov 29, 2005 |
| Last update posted | Jun 2, 2009 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: